Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are the FTSE 100, DAX, Dow, Bitcoin, Ethereum, Gold,
Traders Cafe with Zak Mir: Bulletin Board Heroes, Tuesday 29th September 2026
Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are the FTSE 100, DAX, Dow, Bitcoin, Ethereum, Gold,
Traders Cafe with Zak Mir: Bulletin Board Heroes, Friday 25th September 2026
Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are the FTSE 100, DAX, Dow, Bitcoin, Ethereum, Gold,
Traders Cafe with Zak Mir: Bulletin Board Heroes, Wednesday 23rd September 2026
Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are the FTSE 100, DAX, Dow, Bitcoin, Ethereum, Gold,
Traders Cafe with Zak Mir: Bulletin Board Heroes, Tuesday 22nd September 2026
Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are the FTSE 100, DAX, Dow, Bitcoin, Ethereum, Gold,
RNS Hotlist with Zak Mir: OXB, ECO, HUI, TAP, SRVL & EST
Oxford Biomedica (OXB), a global quality and innovation-led cell and gene therapy CDMO, today announced interim results for the six months ended 30 June 2026. Revenue growth: constant currency revenue
Traders Cafe with Zak Mir: Bulletin Board Heroes, Weekend Edition, Sunday 20th September 2026
Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are the FTSE 100, DAX, Dow, Bitcoin, Ethereum, Gold,
Trader’s Café With Zak Mir: The Week In Small Caps, Sunday 20th September 2026
Warren Buffett
Oxford Biomedica is now on M&A Alert
It has thus far refused four £9 offers from Swedish investment firm EQT, which is said to be looking at Oxford BioMedica plc (LON: OXB) again now that shares are
Oxford Biomedica revenues rise as new client wins hit record
Oxford Biomedica (LON: OXB) has lowered its full-year 2026 revenue and profitability guidance after changes in customer ordering patterns and delays at its US facility, despite reporting record new client activity
Traders Cafe with Zak Mir: Bulletin Board Heroes, Friday 7th August 2026
Zak Mir takes a charting look at some of the most closely followed small caps on the London Stock Exchange. Today’s charts are the FTSE 100, DAX, Dow, Bitcoin, Ethereum, Gold,
RNS Hotlist with Zak Mir: GDWN, AXL, TLM, OXB, GELN & AMRQ
The Telegraph: The Cambridge diversity scramble that led to Arday fiasco: University accused of ‘going through the motions’ when it appointed its youngest black professor